Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema

Completed · Not applicable

Conditions studied: Atopic Dermatitis

In brief

This three week study will be conducted to determine the safety and efficacy of an over-the-counter (OTC) cream in children with mild to moderate atopic dermatitis.

Key facts

Study ID

NCT01326910

Run by

Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.

People needed

90

Starts

2011-03-01

Expected to finish

2011-06-01

Last updated by the study team

2012-08-03

Who can join

Age: 1 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children ages 6 mo- 18 years
• Any ethnicity
• Diagnosed with atopic dermatitis (AD) per Hanifin-Rajka criteria
• Mild to moderate atopic dermatitis per Rajka-Langeland severity index
• Willing to use only provided cream and body wash for duration of study

You may not qualify if…

• Known sensitivity to investigational products
• Pregnant or breastfeeding
• Severe AD per Rajka-Langeland severity index
• AD requiring class I (super potent) or class II or III (potent) topical steroids
• Requires greater than 2.0 g inhaled or intranasal corticosteroids
• Other skin conditions which may interfere with the scoring of AD

Where it is running

• Hilltop Research — St. Petersburg, Florida, United States
• Hilltop Research — Miamiville, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.